Middle East Digital Therapeutics Market Research Report, Analysis and Forecast

Middle East Digital Therapeutics Market Synopsis

In recent years, there has been a growing demand for digital therapeutics in the Middle East due to several factors. Firstly, the prevalence of lifestyle-related diseases such as diabetes, obesity, and cardiovascular diseases has been on the rise in the region, leading to an increased need for innovative and effective treatments. Secondly, the advancements in technology have enabled the development of digital therapeutics that can address these conditions in a more personalized and accessible manner. Additionally, the increasing availability of digital health solutions and the growing awareness among healthcare providers and patients have driven the growth of the digital therapeutics market in the Middle East.

Moreover, the rising healthcare expenditure and the growing interest in preventative health measures have also contributed to the demand for digital therapeutics in the region. In addition, the increasing adoption of smartphones and the widespread availability of high-speed internet has facilitated the growth of digital health solutions in the Middle East, making it easier for patients to access and utilize these solutions.

The Middle East is a major hub for digital health innovation, with countries like Israel and the United Arab Emirates leading the way in developing digital therapeutics solutions.

According to a recent report by Deloitte, the Middle East digital health market is $4 billion in 2022.

Finally, the increasing focus on improving the quality of healthcare delivery and patient outcomes has also played a key role in driving the demand for digital therapeutics in the Middle East. By leveraging technology and data, digital therapeutics can provide real-time monitoring, personalized feedback, and targeted interventions to improve patient outcomes and quality of life. Thus, the growing demand for digital therapeutics in the Middle East can be attributed to a combination of factors such as the rising prevalence of lifestyle-related diseases, the advancements in technology, and the growing focus on improving healthcare delivery and patient outcomes.

Middle East Digital Therapeutics Market: Overview

Digital therapeutics is a rapidly growing field that uses digital technology to improve health outcomes. The use of digital therapeutics involves the use of software and other digital tools to help people manage various health conditions. This can include using digital tools to help people with diabetes manage their condition, help people lose weight, to help people manage cardiovascular diseases, respiratory diseases and a variety of other health conditions

The digital therapeutics industry has been growing in popularity in recent years as healthcare providers, patients and caregivers have become increasingly interested in using technology to improve health outcomes. Patients are looking for more convenient and accessible ways to manage their health, and digital therapeutics provides a solution to this need. Digital therapeutics can be used by patients in the comfort of their own homes and can be accessed from anywhere with an internet connection. This is particularly important for people living in remote areas who might not have access to traditional healthcare services.

Digital therapeutics can also be used by healthcare providers as a tool for delivering care. Providers can use digital tools to monitor patients, deliver care and track health outcomes. Digital therapeutics can also be used by caregivers, who can use digital tools to monitor the health of the people they care for and provide support.

Overall, digital therapeutics is a rapidly growing field that offers a range of benefits to patients, healthcare providers and caregivers. With its potential to improve health outcomes, increase access to care and reduce costs, digital therapeutics is poised to play a significant role in the future of healthcare.

Saudi Arabia Digital Therapeutics Market Synopsis

Saudi Arabia’s digital therapeutics market is still relatively nascent but is expected to grow significantly over the coming years. The country has recently announced plans to invest heavily in healthcare technology and digital health solutions, which will likely drive growth in this sector. Additionally, Saudi Arabia’s large population and high levels of internet penetration make it an attractive market for digital therapeutics companies looking to expand their reach. As such, Saudi Arabia’s digital therapeutics market will likely continue to grow at a rapid pace over the coming years.

UAE Digital Therapeutics Market Synopsis

The UAE digital therapeutics market is growing rapidly due to the increasing demand for digital health solutions in the region. The UAE has a large population of tech-savvy individuals who are increasingly turning to digital health solutions for their healthcare needs. This has led to an increase in the number of digital therapeutics companies operating in the region, offering innovative products and services that can help improve patient outcomes. Additionally, the UAE government has been actively promoting the use of digital health solutions, providing incentives and support for companies operating in this space.

Middle East Digital Therapeutics Market: Segmentation

The middle east Digital Therapeutics market has been segmented into Application and End-user.

Based on the Application, the middle east digital therapeutics market is segmented into Diabetes, Weight Management, Cardiovascular Diseases, Respiratory Diseases, and Others. In 2021, diabetes held a significant revenue share. This is largely due to the increasing prevalence of diabetes in the population and the number of people who are being diagnosed with the condition. Additionally, the rising cost of treatments and medications has also contributed to the high revenue share of diabetes. Additionally, the growing awareness of the importance of diabetes management and the growing availability of treatment options has further contributed to the high revenue share of diabetes. For example, the use of insulin pumps as a method of diabetes management is becoming increasingly popular as it is more convenient and efficient than traditional injection methods.

Based on the End-user, the market is classified as Patients and Caregivers. In 2021, the patient segment was expected to dominate the market. The patient segment is expected to dominate the market due to the rising incidence of chronic diseases. This is due to the increasing adoption of remote patient monitoring systems, and the growing demand for home healthcare solutions. In addition, the advancement of digital healthcare platforms and growing awareness of the benefits of telehealth services are further driving the growth of the patient segment. For instance, due to the COVID-19 pandemic, the demand for telehealth services has increased significantly, as patients opt for remote consultations to reduce the risk of infection.

Recent Developments

In 2021, the Middle East Digital Therapeutics space saw several exciting developments. In April, the UAE-based digital health company, Health at Hand, announced its merger with the Saudi Arabian healthcare provider, Seha. The merger will enable Health at Hand to expand its reach in the Middle East and provide more comprehensive digital health services to patients in the region.
In May, Dubai-based digital therapeutics company, Meddy Health, launched its first product – a mobile app that provides personalized mental health support for users. The app is designed to help users manage their mental health through evidence-based cognitive behavioural therapy (CBT) techniques and other therapeutic activities.
In June, Saudi Arabia’s Ministry of Health announced a partnership with US-based digital therapeutics company Livongo to launch a national diabetes prevention program. The program will use Livongo’s technology platform to provide personalized coaching and support for people with prediabetes or at risk of developing diabetes.
In July, Dubai-based startup NourishMe launched its first product – an AI-powered nutrition tracking app that helps users track their food intake and make healthier dietary choices. The app also provides personalized nutrition advice based on user data and lifestyle habits.
Finally, in August 2021, Saudi Arabia’s Ministry of Health announced a partnership with US-based digital therapeutics company Omada Health to launch a national obesity prevention program. The program will use Omada’s technology platform to provide personalized coaching and support for people who are overweight or obese.

In 2021, there were several acquisitions in the Middle East Digital Therapeutics company space.

In February 2021, the Saudi Arabian digital therapeutics company, Diyar Health, was acquired by the global healthcare provider, Al Borg Medical Laboratories. The acquisition was part of Al Borg’s strategy to expand its digital health capabilities and provide more comprehensive care to its patients.
In March 2021, the UAE-based digital therapeutics company, Meddy Health, was acquired by the global healthcare provider, VPS Healthcare. The acquisition was part of VPS’s strategy to expand its digital health capabilities and provide more comprehensive care to its patients.
In April 2021, the UAE-based digital therapeutics company, MyHealthcare Clinic was acquired by the global healthcare provider Aster DM Healthcare. The acquisition was part of Aster’s strategy to expand its digital health capabilities and provide more comprehensive care to its patients.